Moderate alcohol intake has no impact on acute and chronic progressive anti-thy1 glomerulonephritis

American Journal of Physiology - Renal Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  Peters, Harm ^a,c   Martini, Sebastian ^a   Woydt, Raiko ^a   Rückert, Matthias ^a   Shimizu, Fuijo ^b   Kawachi, Hiroshi ^b   Liefeldt, Lutz ^a   Krämer, Stephanie ^a   Neumayer, Hans H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Beer; Fibrosis; Inducible nitric oxide production; Transforming growth factor

Indexed keywords

ALCOHOL; FIBRONECTIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; NITRIC OXIDE; NITRITE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE DISEASE; ALCOHOL CONSUMPTION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEER; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; GLOMERULONEPHRITIS; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0037405534     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00328.2002     Document Type: Article

References (37)

1. Bagchus WM, Hoedemaeker PJ, Rozing J, and Bakker WW. Glomerulonephritis induced by monoclonal anti-thy 1.1 antibodies. Lab Invest 55: 680-687, 1986.
2. Bergstrom J. Nutrition in chronic renal failure. Nefrologia 20, Suppl 3: 52-58, 2000.
3. Bircher G. Nutrition in chronic renal failure. In: Clinical Nephrology, edited by Johnson RJ and Feehally J. New York: Harcourt, 2000, p. 75.1-75.7.
4. Border WA and Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994.
5. Chen J, Clemens DL, Cederbaum AI, and Gao B. Ethanol inhibits the JAK-STAT signaling pathway in freshly isolated rat hepatocytes but not in cultured hepatocytes or HepG2 cells: evidence for a lack of involvement of ethanol metabolism. Clin Biochem 34: 203-209, 2001.
6. Choudhry MA, Messingham KA, Namak S, Colantoni A, Fontanilla CV, Duffner LA, Sayeed MM, and Kovacs EJ. Ethanol exacerbates T cell dysfunction after thermal injury. Alcohol 21: 239-243, 2000.
7. Corder R, Douthwaite JA, Lees DM, Khan NQ, Viseu Dos Santos AC, Wood EG, and Carrier MJ. Endothelin-1 synthesis reduced by red wine. Nature 414: 863-864, 2001.
8. Denke MA. Nutritional and health benefits of beer. Am J Med Sci 320: 320-326, 2000.
9. El Mas MM and Abdel-Rahman AA. Radiotelemetric evaluation of hemodynamic effects of long-term ethanol in spontaneously hypertensive and Wistar-Kyoto rats. J Pharmacol Exp Ther 292: 944-951, 2000.
10. Feng AN, Chen YL, Chen YT, Ding YZ, and Lin SJ. Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-fed rabbits. Circulation 100: 2254-2259, 1999.
11. Garriga J, Adanero E, Fernandez-Sola J, Urbano-Marquez A, and Cusso R. Ethanol inhibits skeletal muscle cell proliferation and delays its differentiation in cell culture. Alcohol 35: 236-241, 2000.
12. Goldberg IJ, Mosca L, Piano MR, and Fisher EA. AHA Science Advisory: wine and your heart: a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation 103: 472-475, 2001.
13. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, and Tannenbaum SR. Analysis of nitrate, nitrite and 15N-nitrate in biological fluids. Anal Biochem 126: 131-138, 1982.
14. Greenberg SS, Jie O, Zhao X, Wang JF, and Giles TD. The potential mechanism of induction of inducible nitric oxide synthase mRNA in alveolar macrophages by lipopolysaccharide and its suppression by ethanol, in vivo. Alcohol Clin Exp Res 22: 260S-265S, 1998.
15. Grenett HE, Wolkowicz PE, Benza RL, Tresnak JK, Wheeler-And CG, and Booyse FM. Identification of a 251-bp fragment of the PAI-1 gene promoter that mediates the ethanol-induced suppression of PAI-1 expression. Alcohol Clin Exp Res 25:629-636, 2001.
16. Gu JW, Elam J, Sartin A, Li W, Roach R, and Adair TH. Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis. Am J Physiol Regul Integr Comp Physiol 281: R365-R372, 2001.
17. Klahr S, Schreiner G, and Ichikawa I. The progression of renal disease. N Engl J Med 318: 1657-1666, 1988.
18. Kotter K and Klein J. Ethanol inhibits astroglial cell proliferation by disruption of phospholipase D-mediated signaling. J Neurochem 73: 2517-2523, 1999.
19. Magnotti RA, Stephens GW, Rogers RK, and Pesce AJ. Microplate measurement of urinary albumin and creatinine. Clin Chem 35: 1371-1375, 1989.
20. Mazzaglia G, Britton AR, Altmann DR, and Chenet L. Exploring the relationship between alcohol consumption and non-fatal or fatal stroke: a systematic review. Addiction 96: 1743-1756, 2001.
21. Meister KA, Whelan EM, and Kava R. The health effects of moderate alcohol intake in humans: an epidemiologic review. Crit Rev Clin Lab Sci 37: 261-296, 2000.
22. Mitch WE. Dietary therapy in uremia: the impact on nutrition and progressive renal failure. Kidney Int Suppl 75: S38-S43, 2000.
23. Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawachi H, and Shimizu F. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 55: 877-889, 1999.
24. Narita I, Border WA, Ketteler M, and Noble NA. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 72: 17-24, 1995.
25. Peters H, Border WA, and Noble NA. Angiotensin II and L-arginine in tissue fibrosis: more than blood pressure. Kidney Int 51: 1481-1486, 1997.
26. Peters H, Border WA, and Noble NA. Angiotensin II blockade and low protein diet produce additive therapeutic effects on experimental glomerulonephritis. Kidney Int 57: 1493-1501, 1999.
27. Peters H, Border WA, and Noble NA. From rats to men: a perspective on dietary L-arginine supplementation in human renal disease. Nephrol Dial Transplant 14: 1640-1650, 1999.
28. Peters H, Border WA, and Noble NA. L-Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis. Kidney Int 55: 2264-2273, 1999.
29. Peters H, Noble NA, and Border WA. Targeting TGF-β over-expression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 54: 1575-1583, 1998.
30. , Peters H, Rückert M, Krämer S, Border WA, Noble NA, and Neumayer HH. L-Arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis. Kidney Int. In press.
31. Rennard SI, Berg R, Martin GR, Foidart JM, and Robey PG. Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 104: 205-214, 1980.
32. Ruitenberg A, van Swieten JC, Witteman JC, Mehta KM, van Duijn CM, Hofman A, and Breteler MM. The Rotterdam Study. Lancet 359: 281-286, 2002.
33. Saibara T, Ono M, Iwasaki S, Maeda T, Onishi S, Hayashi-And Y, and Enzan H. Effects of ethanol on L-arginine transport in rat Ito cells in relation to nitric oxide production. Alcohol Clin Exp Res 25: 39S-45S, 2001.
34. Syapin PJ, Militante JD, Garrett DK, and Ren L. Cytokine-induced iNOS expression in C6 glial cells: transcriptional inhibition by ethanol. J Pharmacol Exp Ther 298: 744-752, 2001.
35. Utkan T, Yildiz F, Ilbay G, Ozdemirci S, Erden BF, Gacar N, and Ulak G. Blood pressure and vascular reactivity to endothelin-1, phenylephrine, serotonin, KC1 and acetylcholine following chronic alcohol consumption in vitro. Fundam Clin Pharmacol 15: 157-165, 2001.
36. Vasdev S, Ford CA, Longerich L, Parai S, and Gadag V. Antihypertensive effect of low ethanol intake in spontaneously hypertensive rats. Mol Cell Biochem 200: 85-92, 1999.
37. Venkov CD, Myers PR, Tanner MA, Su M, and Vaughan DE. Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression. Thromb Haemost 81: 638-642, 1999.